Compile Data Set for Download or QSAR
maximum 50k data
Found 606 with Last Name = 'spring' and Initial = 'dr'
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644447(5-((2-(4-((3-cyano-4- cyclobutoxybenzyl) amino)but...)
Affinity DataIC50:  0.145nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644585((R)-5-((1-(4-((3-fluoro-4-(trifluoromethoxy)benzyl...)
Affinity DataIC50:  0.180nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644445(5-((2-(4-((3-cyano-4- cyclopropylbenzyl) amino)but...)
Affinity DataIC50:  0.197nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644580(5-((2-(4-((3-((1H-pyrazol-4-yl)methyl)-5-(trifluor...)
Affinity DataIC50:  0.201nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644448(5-((2-(4-((3-chloro- 5-(cyanomethyl) benzyl)amino)...)
Affinity DataIC50:  0.203nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644564(5-((2-(4-((3- (oxazol-5- ylmethyl)-5- (trifluorome...)
Affinity DataIC50:  0.217nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644439(5-((2-(4-((3-Chloro-4-cyclopropylbenzyl)amino)buto...)
Affinity DataIC50:  0.221nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644578(5-((2-(4-((3- (furan-3- ylmethyl)-5- (trifluoromet...)
Affinity DataIC50:  0.223nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644583(5-((2-(4- ((3,5- difluoro-4- (trifluoro- methoxy) ...)
Affinity DataIC50:  0.236nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644417(5-((2-(4-((3-chloro-4- (cyclopentyloxy) benzyl)ami...)
Affinity DataIC50:  0.244nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644520(5-(2-(4-((3- bromo-5- (trifluoro- methoxy) benzyl)...)
Affinity DataIC50:  0.248nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644440(5-((2-(4-((3-chloro-4- cyclopropoxybenzyl) amino)b...)
Affinity DataIC50:  0.248nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644506(5-(3-(4-((3- fluoro-4- (trifluoro- methoxy) benzyl...)
Affinity DataIC50:  0.258nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644511(5-((2-(4-((3- chloro-5- (1-cyano- cyclopropyl) ben...)
Affinity DataIC50:  0.263nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644577(5-((2-(4-((3- ((1H-imidazol- 1-yl)methyl)-5- (trif...)
Affinity DataIC50:  0.265nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644426(5-((2-(4-((3- cyano-4- cyclobutoxy- benzyl)amino) ...)
Affinity DataIC50:  0.278nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644409(5-((2-(4-((3-chloro- 4-(trifluoromethoxy) benzyl)a...)
Affinity DataIC50:  0.298nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644513(5-((2-(4-((3- (cyanomethyl)- 5-(trifluoro- methoxy...)
Affinity DataIC50:  0.304nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644408(5-((2-(4-(((2-Chloro-[1,1′-biphenyl]-4-yl)me...)
Affinity DataIC50:  0.306nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644521(5-(2-(4-((3,5-difluoro-4-(trifluoromethoxy)benzyl)...)
Affinity DataIC50:  0.318nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644507(5-(3-(4-((3- chloro-5- (cyanomethyl) benzyl)amino)...)
Affinity DataIC50:  0.324nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644534(5-(2-(4-((3- chloro-5-(1- cyano- cyclopropyl) benz...)
Affinity DataIC50:  0.333nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644519(5-(2-(4-((3- chloro-5- (trifluoro- methoxy) benzyl...)
Affinity DataIC50:  0.342nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644434(5-((2-(4-((3- fluoro-4- (trifluoromethoxy) benzyl)...)
Affinity DataIC50:  0.346nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644545(5-((2-(4-((3- (cyanomethyl)- 5-(2,2,2- trifluoroet...)
Affinity DataIC50:  0.349nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644498(5-(2-(4-((3- fluoro-4- (trifluoro- methoxy) benzyl...)
Affinity DataIC50:  0.354nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644516(5-(2-(4-((3- (cyanomethyl)- 5-(trifluoro- methoxy)...)
Affinity DataIC50:  0.354nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644493((R)-5-((1-(4-((3-chloro-4-(trifluoromethoxy)benzyl...)
Affinity DataIC50:  0.359nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644491((S)-5-((1-(4-((3-Chloro-4-(trifluoromethoxy)benzyl...)
Affinity DataIC50:  0.361nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644522(5-(2-(4-((3- cyclopropyl-5- (trifluoro- methoxy) b...)
Affinity DataIC50:  0.365nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644431(5-((2-(4-((3-Chloro-4-cyclobutoxybenzyl)amino)buto...)
Affinity DataIC50:  0.366nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644537(5-(2-(4-((3- methyl-4- (trifluoro- methoxy) benzyl...)
Affinity DataIC50:  0.370nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644416(5-((2-(4-((3-chloro-4- cyclobutoxybenzyl) amino)bu...)
Affinity DataIC50:  0.372nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644412(5-((2-(4-(((2- chloro-2'- (hydroxymethyl)- [1,1'-b...)
Affinity DataIC50:  0.378nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644421(5-((2-(4-((3-Chloro-4-(trifluoromethoxy)benzyl)ami...)
Affinity DataIC50:  0.382nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644570(5-((2-(4-((3-(2- hydroxyethyl)-5- (trifluoromethox...)
Affinity DataIC50:  0.390nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644446(5-((2-(4-((3-Chloro-5-(cyanomethyl)benzyl)amino)bu...)
Affinity DataIC50:  0.403nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644538(5-(2-(4-((3- methoxy-4- (trifluoro- methoxy) benzy...)
Affinity DataIC50:  0.403nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644452(5-(2-(4-((3-Chloro-4-(trifluoromethoxy)benzyl)amin...)
Affinity DataIC50:  0.404nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644518(5-(2-(4-((4- chloro-3- (trifluoro- methoxy) benzyl...)
Affinity DataIC50:  0.409nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644517(5-(2-(4-((3- bromo-4- (trifluoro- methoxy) benzyl)...)
Affinity DataIC50:  0.411nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644500(5-(2-(4-((3- (cyanomethyl)- 5- fluorobenzyl) amino...)
Affinity DataIC50:  0.418nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644407(5-((2-(4-((4-cyclobutoxy-3-(hydroxymethyl)benzyl)a...)
Affinity DataIC50:  0.425nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644462(5-((2-(4-((3- (cyanomethyl)-5- (trifluoromethyl) b...)
Affinity DataIC50:  0.427nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644586((R)-5-((1-(4-((3-fluoro-4-(trifluoromethoxy)benzyl...)
Affinity DataIC50:  0.428nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644536(5-(2-(4-((3- cyclopropyl-4- (trifluoro- methoxy) b...)
Affinity DataIC50:  0.432nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644443(5-((2-(4-((3- (hydroxymethyl) benzyl)amino) butoxy...)
Affinity DataIC50:  0.436nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644512(5-(2-(4-((3- (cyanomethyl)- 5-(trifluoro- methoxy)...)
Affinity DataIC50:  0.437nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644508(5-(3-(4-((3- (cyanomethyl)- 5-(trifluoro- methyl) ...)
Affinity DataIC50:  0.453nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase II subunit alpha [2-329](Homo sapiens (Human))
Cambridge Enterprise

US Patent
LigandPNGBDBM644547(5-(3-(4-((3- cyclopropyl-4- (trifluoro- methoxy) b...)
Affinity DataIC50:  0.457nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 606 total ) | Next | Last >>
Jump to: